Ecopipam

Generic Name: Ecopipam

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₉H_₂₀ClNO

CAS Number: 112108-01-7

Unique Ingredient Identifier: 0X748O646K

Background: Ecopipam has been used in trials studying the treatment of Tourette's Syndrome, Lesch-Nyhan Disease, Pathological Gambling, and Self-injurious Behavior.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble

Phase 2

Completed

Conditions: Pathological Gambling

Interventions: Drug: Ecopipam

First Posted Date: 2010-10-06

Last Posted Date: 2024-05-14

Lead Sponsor: Emalex Biosciences Inc.

Target Recruit Count: 34

Registration Number: NCT01215357

Locations: 🇺🇸
University of Minnesota School of Medicine, Minneapolis, Minnesota, United States
🇺🇸
Carver College of Medicine, University of Iowa, Iowa City, Iowa, United States
🇺🇸
Yale University, New Haven, Connecticut, United States

and more 1 locations

Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease

Phase 1

Completed

Conditions: Lesch-Nyhan Disease

Interventions: Drug: Ecopipam

First Posted Date: 2010-02-09

Last Posted Date: 2013-04-18

Lead Sponsor: Psyadon Pharma

Target Recruit Count: 5

Registration Number: NCT01065558

Locations: 🇺🇸
Emory Univesity, Atlanta, Georgia, United States
🇺🇸
University of California at San Diego, San Diego, California, United States

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy